Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which ...

According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy ...

In conclusion, I see 2025 as a year in which the patient will still be centre-stage. But, in order for that to happen ...